(FOLD) Amicus Therapeutics - Performance -39.6% in 12m
FOLD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-63.82%
#88 in Peer-Group
Rel. Strength
12.62%
#6737 in Stock-Universe
Total Return 12m
-39.59%
#115 in Peer-Group
Total Return 5y
-61.86%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 49.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 12.09 USD |
| 52 Week Low | 5.64 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 71.51 |
| Buy/Sell Signal +-5 | 0.75 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: FOLD (-39.6%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: FOLD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FOLD
| Total Return (including Dividends) | FOLD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.41% | 4.38% | 4.99% |
| 3 Months | -25.53% | 5.22% | 10.23% |
| 12 Months | -39.59% | -7.16% | 14.42% |
| 5 Years | -61.86% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | FOLD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -70.5% | 3.5% | 79.1% |
| 3 Months | -85.6% | 75.7% | 95.5% |
| 12 Months | -90.3% | -85.1% | 44.7% |
| 5 Years | -34.9% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th39.50 | -7.46% | -8.00% |
| 3 Month | %th12.50 | -29.23% | -32.45% |
| 12 Month | %th42.50 | -34.93% | -47.21% |
| 5 Years | %th64.00 | -49.41% | -81.85% |
FAQs
Does Amicus Therapeutics (FOLD) outperform the market?
No,
over the last 12 months FOLD made -39.59%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months FOLD made -25.53%, while XBI made 5.22%.
Performance Comparison FOLD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
FOLD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.9% | -8.4% | -42.9% | -54% |
| US NASDAQ 100 | QQQ | 3.3% | -8.8% | -44.3% | -53% |
| German DAX 40 | DAX | 3.9% | -2.9% | -54.4% | -70% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.7% | -7.6% | -43.3% | -57% |
| Hongkong Hang Seng | HSI | 4.9% | -10.5% | -61.4% | -76% |
| India NIFTY 50 | INDA | 4% | -5.4% | -40.2% | -39% |
| Brasil Bovespa | EWZ | 0.3% | -11.4% | -65.8% | -53% |
FOLD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3% | -9.1% | -47.1% | -66% |
| Consumer Discretionary | XLY | 1.9% | -6.3% | -36% | -59% |
| Consumer Staples | XLP | 2.7% | -3.3% | -42.3% | -50% |
| Energy | XLE | 2.3% | -9.5% | -38% | -38% |
| Financial | XLF | 2.8% | -7% | -46% | -68% |
| Health Care | XLV | 4% | -5.9% | -35.3% | -35% |
| Industrial | XLI | 2.1% | -7.6% | -49.6% | -64% |
| Materials | XLB | -0.2% | -9.2% | -47.1% | -47% |
| Real Estate | XLRE | 3.8% | -4.3% | -41.4% | -53% |
| Technology | XLK | 3.4% | -12.5% | -45.8% | -51% |
| Utilities | XLU | 4.2% | -2.9% | -44.1% | -63% |
| Aerospace & Defense | XAR | 2.7% | -11% | -61.2% | -88% |
| Biotech | XBI | 3.3% | -7.8% | -28.7% | -32% |
| Homebuilder | XHB | -2% | -15% | -36.8% | -46% |
| Retail | XRT | 0.3% | -8.9% | -37.7% | -50% |
FOLD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2% | -12.1% | -34.4% | -33% |
| Natural Gas | UNG | 7.8% | 5.2% | -26.7% | -34% |
| Gold | GLD | 4.4% | -2.6% | -62.1% | -83% |
| Silver | SLV | 4.4% | -8.6% | -59.5% | -63% |
| Copper | CPER | 0.7% | -9.6% | -63.4% | -57% |
FOLD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.7% | -6.6% | -38.3% | -40% |
| iShares High Yield Corp. Bond | HYG | 4.4% | -5.3% | -40.9% | -50% |